CBT for Insomnia in Children with Autism
(RECHArge Trial)
Trial Summary
What is the purpose of this trial?
Children with Autism Spectrum Disorder (ASD) and insomnia, and their parent(s) will undergo 4 sessions of behavioral therapy for sleep problems followed by 4 bimonthly booster sessions. Children and their families will be randomly assigned to one of three conditions: cognitive behavioral therapy (in-person), cognitive behavioral therapy (remote), or behavioral therapy (remote). Arousal will be measured through heart-rate variability. Sleep and secondary outcomes (child daytime behavior, parent sleep) will be collected at baseline (weeks 1-2 before starting the treatment), post-treatment (weeks 6-8 from baseline), 6-month follow-up, and 12-month follow-up.
Will I have to stop taking my current medications?
The trial does not require stopping all medications, but if your child is taking stimulants, sleep medications, or melatonin, they must have been stable on these for at least 3 months before joining the trial.
What data supports the effectiveness of the treatment for insomnia in children with autism?
Research shows that Cognitive Behavioral Therapy for Childhood Insomnia (CBT-CI), whether delivered in-person or via telehealth, can improve sleep and reduce challenging behaviors in children with autism. Studies found that both children and their parents experienced better sleep and reduced fatigue, indicating that CBT-CI is a promising treatment for insomnia in this population.12345
Is Cognitive Behavioral Therapy for Insomnia safe for children with autism?
How does the treatment for insomnia in children with autism differ from other treatments?
This treatment is unique because it uses Cognitive Behavioral Therapy (CBT) specifically adapted for children with autism, and it can be delivered remotely via telehealth, making it more accessible for families who may have difficulty attending in-person sessions. It not only improves sleep but also enhances daytime functioning and reduces challenging behaviors in children with autism.12346
Research Team
Christina McCrae, PhD
Principal Investigator
University of Missouri-Columbia
Eligibility Criteria
This trial is for children aged 6-12 with Autism Spectrum Disorder and chronic insomnia, who have a verbal IQ of at least 70. Their parent or guardian must be able to read English at a 5th-grade level and live with the child. Kids on stable sleep-related meds can join, but those with untreated medical issues affecting sleep or taking certain other drugs cannot.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 4 sessions of behavioral therapy for sleep problems followed by 4 bimonthly booster sessions
Follow-up
Participants are monitored for sleep and secondary outcomes at 6-month and 12-month intervals
Treatment Details
Interventions
- In-Person CBT for insomnia in children with autism
- Remote CBT for insomnia in children with autism
- Remote sleep hygiene and related education (SHARE) for insomnia in children with autism
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Missouri-Columbia
Lead Sponsor
United States Department of Defense
Collaborator